Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health - Image 1

£92.14

Edward Elgar Publishing Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Name: Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health
Brand: Edward Elgar Publishing
Price: 92.14 GBP
Availability: InStock

Law

It has never been this cheap. We have no record of a lower price.

£92 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price

Price Analysis

Most common price: £92 (35 days, 100.0%)

Price range: £92 - £92

Price levels: 1 different prices over 35 days

Description

Since the 1970s, the pharmaceutical industry has experienced major shifts in research, development, trade, and production. This book examines how these changes, along with evolving regulatory frameworks and intellectual property rights, affect the global pharmaceutical sector. Providing essential empirical evidence, the text analyzes the impact of these shifts on access to medicines in developing countries. The research uses a consistent methodology to study nine different developing nations, including major pharmaceutical producers like China and India. This makes it a valuable resource for understanding the connection between legal frameworks and public health outcomes in emerging markets.

Key Features

Provides empirical evidence regarding the impact of pharmaceutical industry changes on global medicine access.

Analyzes the relationship between evolving regulatory frameworks and intellectual property rights.

Includes detailed studies on nine developing countries to offer a broad geographic perspective.

Covers major pharmaceutical producing nations such as China and India.

Utilizes a common methodology across all studies for consistent and reliable research results.

Examines shifts in research and development paradigms since the 1970s.

Product Specifications

Brand: Edward Elgar Publishing
Format: hardcover
ASIN: 1849800146
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 30 November 2011
Listed Since: 19 April 2010

Barcode

No barcode data available

Edward Elgar Publishing Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Global Issues in Pharmaceutical Marketing

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Government, Big Pharma, and The People: A Century of Dis-Ease

A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Pharmaceuticals, Corporate Crime and Public Health

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Routledge Pharmaceutical Industry and Public Policy in India

Oxford University Press - Balancing Wealth and Health Book

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Springer - Innovation and Marketing in Pharmaceutical Industry

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Pharmaceutical Public Policy

The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)

Global Pharmaceutical Policy

The Law and Ethics of the Pharmaceutical Industry